Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Neuropeptides affect hair growth and could be used to control it.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Trazodone might help reverse post finasteride syndrome.

Trichotillomania was successfully treated with risperidone and naltrexone.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.

CTP-543 is generally safe for treating alopecia areata.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

Platelet-rich plasma treatment is more effective and cost-efficient than epinephrine for healing bleeding peptic ulcers, with fewer complications and rebleeding cases.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

PT-20 did not significantly improve gray hair repigmentation.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Trichohyalin is modified by enzymes to form strong structures in hair cells.